Cargando…
Vaccine allergy: evidence to consider for COVID-19 vaccines
Whereas the COVID-19 pandemic has changed our lives worldwide, we hope that vaccination can combat the disease. We propose how to evaluate suspected severe allergic reactions to the vaccines so that as many as possible may be safely vaccinated. RECENT FINDINGS: Rare cases of severe allergic reaction...
Autores principales: | Nilsson, Lennart, Csuth, Ágnes, Storsaeter, Jann, Garvey, Lene H., Jenmalm, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270228/ https://www.ncbi.nlm.nih.gov/pubmed/34091550 http://dx.doi.org/10.1097/ACI.0000000000000762 |
Ejemplares similares
-
Atopic dermatitis phenotypes and the need for personalized medicine
por: Cabanillas, Beatriz, et al.
Publicado: (2017) -
COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E
por: Csuth, Àgnes, et al.
Publicado: (2022) -
Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013) -
Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016) -
Early Australian experience in the maintenance of schizophrenia management with 3-monthly paliperidone palmitate
por: Pai, Nagesh, et al.
Publicado: (2018)